Risk assessment of lymph node metastasis and comparison of treatment modalities for low-risk T1b colorectal cancer: a meta-analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
3331 cases of low-risk T1b CRC, pooled from 22 studies.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
In such cases, given the low LNM rate, appropriately expanding the indications for endoscopic treatment and implementing rigorous follow-up post-endoscopic resection may represent a feasible strategy for selected patients, especially when balancing risks of unnecessary surgery. Otherwise, surgical resection remains the preferred treatment.
[BACKGROUND AND AIMS] The uncertainty surrounding the risk of recurrence and metastasis in T1 colorectal cancer (CRC) with solely deep submucosal invasion (DSI, defined as T1b, submucosal invasion exc
- 95% CI 1.3-3.8
- 연구 설계 meta-analysis
APA
Tian M, Wu K, et al. (2025). Risk assessment of lymph node metastasis and comparison of treatment modalities for low-risk T1b colorectal cancer: a meta-analysis.. Surgical endoscopy, 39(12), 8301-8314. https://doi.org/10.1007/s00464-025-12240-z
MLA
Tian M, et al.. "Risk assessment of lymph node metastasis and comparison of treatment modalities for low-risk T1b colorectal cancer: a meta-analysis.." Surgical endoscopy, vol. 39, no. 12, 2025, pp. 8301-8314.
PMID
40987891 ↗
Abstract 한글 요약
[BACKGROUND AND AIMS] The uncertainty surrounding the risk of recurrence and metastasis in T1 colorectal cancer (CRC) with solely deep submucosal invasion (DSI, defined as T1b, submucosal invasion exceeding 1000 μm) as a high-risk factor has led to controversial treatment strategies. This meta-analysis aims to assess the risk of lymph node metastasis in T1 CRC patients presenting with a solitary risk factor of DSI. Furthermore, it compares the effectiveness and safety of endoscopic resection, surgery after endoscopic resection, and surgical resection in this context, offering valuable insights for clinical decision-making.
[METHODS] PubMed, Embase, and the Cochrane Library electronic databases were searched to identify available studies published up to November 30, 2024. Random- or fixed-effects models were applied in the meta-analyses. Heterogeneity and consistency were evaluated.
[RESULTS] The analysis encompassed 3331 cases of low-risk T1b CRC, pooled from 22 studies. The lymph node metastasis (LNM) rate of low-risk T1b CRC is 2.5% (95% CI 1.3-3.8%). Patients of this kind treated with endoscopic resection, surgery after endoscopic resection, or surgical resection alone do not differ statistically significantly in terms of recurrence rates (P = 0.28) or disease-specific survival (DSS) rate (P = 0.66). In addition, R0 resection could be achieved with endoscopic resection in the majority of patients, without serious adverse events reported in documented cases.
[CONCLUSIONS] For patients with early-stage colorectal cancer presenting as DSI and devoid of other risk factors, treatment should be individualized. In such cases, given the low LNM rate, appropriately expanding the indications for endoscopic treatment and implementing rigorous follow-up post-endoscopic resection may represent a feasible strategy for selected patients, especially when balancing risks of unnecessary surgery. Otherwise, surgical resection remains the preferred treatment.
[METHODS] PubMed, Embase, and the Cochrane Library electronic databases were searched to identify available studies published up to November 30, 2024. Random- or fixed-effects models were applied in the meta-analyses. Heterogeneity and consistency were evaluated.
[RESULTS] The analysis encompassed 3331 cases of low-risk T1b CRC, pooled from 22 studies. The lymph node metastasis (LNM) rate of low-risk T1b CRC is 2.5% (95% CI 1.3-3.8%). Patients of this kind treated with endoscopic resection, surgery after endoscopic resection, or surgical resection alone do not differ statistically significantly in terms of recurrence rates (P = 0.28) or disease-specific survival (DSS) rate (P = 0.66). In addition, R0 resection could be achieved with endoscopic resection in the majority of patients, without serious adverse events reported in documented cases.
[CONCLUSIONS] For patients with early-stage colorectal cancer presenting as DSI and devoid of other risk factors, treatment should be individualized. In such cases, given the low LNM rate, appropriately expanding the indications for endoscopic treatment and implementing rigorous follow-up post-endoscopic resection may represent a feasible strategy for selected patients, especially when balancing risks of unnecessary surgery. Otherwise, surgical resection remains the preferred treatment.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults.
- Elucidating the mechanisms of bisphenols-induced male spermatogenesis disorder via network toxicology, molecular docking and bioinformatics.
- Enocyanin Synergistically Enhances Sorafenib Sensitivity in Hepatocellular Carcinoma via Ferroptosis Induction Associated with p62/Keap1/Nrf2/HO-1 Pathway Inhibition.
- Securinine suppresses pancreatic cancer progression by activating the p38 MAPK pathway to upregulate CHOP and induce endoplasmic reticulum stress.
- Design, synthesis and biological evaluation of novel urolithin derivatives targeting liver cancer cells.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.